{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:22:00Z","timestamp":1780471320913,"version":"3.54.1"},"reference-count":49,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>During the coronavirus disease 2019 pandemic, several studies have described a distinctive cutaneous manifestation with a clinical picture resembling chilblains or chilblain lupus in young patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To report the histopathologic description of a series of chilblainlike lesions appearing in the context of the severe acute respiratory syndrome coronavirus 2 epidemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>The study included 13 patients with cutaneous acral lesions resembling chilblains occurring in the setting of suspected severe acute respiratory syndrome coronavirus 2 infection with available skin biopsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Two main histopathologic patterns were observed: a chilblainlike histopathologic pattern (10 of 13 cases; 77%) and a thrombotic vasculopathy pattern (3 of 13 cases; 23%). The chilblainlike histopathologic pattern featured a superficial and deep perivascular infiltrate of lymphocytes of varying intensity. This infiltrate was sometimes peri-eccrine and alterations of eccrine glands were present in most cases. Vacuolar alteration of the basal layer of the epidermis was found in a majority of patients. Lichenoid interface dermatitis was rarely present. The thrombotic vasculopathy pattern featured an absent or mild inflammatory infiltrate, multiple intraluminal fibrin thrombi, and ischemic epidermal necrosis. In both patterns, no true vasculitis was observed. No patient tested positive for severe acute respiratory syndrome coronavirus 2 by polymerase chain reaction, possibly because these lesions may represent late cutaneous manifestations of the disease or are associated with an early effective immune response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>The relationship of chilblainlike lesions to severe acute respiratory syndrome coronavirus 2 requires further investigations. Histopathologic features mimic chilblains, chilblain lupus, and, less frequently, a thrombotic vasculopathy. Response to viral infection might trigger diverse mechanisms leading to the 2 histopathologic patterns described.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2020-0613-sa","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T18:00:22Z","timestamp":1602266422000},"page":"137-144","source":"Crossref","is-referenced-by-count":15,"title":["Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic"],"prefix":"10.5858","volume":"145","author":[{"given":"Pierre","family":"Sohier","sequence":"first","affiliation":[{"name":"The Department of Pathology (Sohier, Laurent-Roussel), Assistance Publique-H\u00f4pitaux de Paris, AP-HP Centre-Universit\u00e9 de Paris, Paris, France"},{"name":"Universit\u00e9 de Paris, Paris, France (Sohier, Dupin, Aractingi)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Matar","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology (Matar, Dupin, Aractingi), Assistance Publique-H\u00f4pitaux de Paris, AP-HP Centre-Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Meritet","sequence":"additional","affiliation":[{"name":"Department of the Laboratory of Virology (Meritet), Assistance Publique-H\u00f4pitaux de Paris, AP-HP Centre-Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Laurent-Roussel","sequence":"additional","affiliation":[{"name":"The Department of Pathology (Sohier, Laurent-Roussel), Assistance Publique-H\u00f4pitaux de Paris, AP-HP Centre-Universit\u00e9 de Paris, Paris, France"},{"name":"Universit\u00e9 de Paris, Paris, France (Sohier, Dupin, Aractingi)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dupin","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology (Matar, Dupin, Aractingi), Assistance Publique-H\u00f4pitaux de Paris, AP-HP Centre-Universit\u00e9 de Paris, Paris, France"},{"name":"Universit\u00e9 de Paris, Paris, France (Sohier, Dupin, Aractingi)"},{"name":"Cutaneous Biology Lab, Institut Cochin, INSERM U1016, UMR8104, Paris, France (Dupin, Aractingi)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Aractingi","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology (Matar, Dupin, Aractingi), Assistance Publique-H\u00f4pitaux de Paris, AP-HP Centre-Universit\u00e9 de Paris, Paris, France"},{"name":"Universit\u00e9 de Paris, Paris, France (Sohier, Dupin, Aractingi)"},{"name":"Cutaneous Biology Lab, Institut Cochin, INSERM U1016, UMR8104, Paris, France (Dupin, Aractingi)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"2021012621544343600_i1543-2165-145-2-137-b01","doi-asserted-by":"crossref","unstructured":"Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798): 270\u2013 273. doi:10.1038\/s41586-020-2012-7","DOI":"10.1038\/s41586-020-2012-7"},{"key":"2021012621544343600_i1543-2165-145-2-137-b02","unstructured":"World Health Organization. Coronavirus disease (COVID-19) weekly epidemiological update. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200824-weekly-epi-update.pdf?sfvrsn=806986d1_4. Published August 24, 2020. Accessed August 26, 2020."},{"key":"2021012621544343600_i1543-2165-145-2-137-b03","doi-asserted-by":"crossref","unstructured":"He F, Deng Y, Li W. Coronavirus disease 2019 (COVID-19): what we know [published online March 14, 2020]? J Med Virol. doi:10.1002\/jmv.25766","DOI":"10.1002\/jmv.25766"},{"key":"2021012621544343600_i1543-2165-145-2-137-b04","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061\u2013 1069. doi:10.1001\/jama.2020.1585","DOI":"10.1001\/jama.2020.1585"},{"key":"2021012621544343600_i1543-2165-145-2-137-b05","doi-asserted-by":"crossref","unstructured":"Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020; 116(10): 1666\u2013 1687. doi:10.1093\/cvr\/cvaa106","DOI":"10.1093\/cvr\/cvaa106"},{"key":"2021012621544343600_i1543-2165-145-2-137-b06","doi-asserted-by":"crossref","unstructured":"Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [published online April 10, 2020]. medRxiv. doi:10.1101\/2020.03.04.20031120","DOI":"10.1101\/2020.03.04.20031120"},{"key":"2021012621544343600_i1543-2165-145-2-137-b07","doi-asserted-by":"crossref","unstructured":"Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020; 115(5): 766\u2013 773. doi:10.14309\/ajg.0000000000000620","DOI":"10.14309\/ajg.0000000000000620"},{"key":"2021012621544343600_i1543-2165-145-2-137-b08","doi-asserted-by":"crossref","unstructured":"Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study [published online April 6, 2020]. Eur Arch Otorhinolaryngol. doi:10.1007\/s00405-020-05965-1","DOI":"10.1007\/s00405-020-05965-1"},{"key":"2021012621544343600_i1543-2165-145-2-137-b09","doi-asserted-by":"crossref","unstructured":"Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China [published online April 10, 2020]. JAMA Neurol. doi:10.1001\/jamaneurol.2020.1127","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"2021012621544343600_i1543-2165-145-2-137-b10","doi-asserted-by":"crossref","unstructured":"Recalcati S. Cutaneous manifestations in COVID-19: a first perspective [published online March 26, 2020]. J Eur Acad Dermatol Venereol. doi:10.1111\/jdv.16387","DOI":"10.1111\/jdv.16387"},{"key":"2021012621544343600_i1543-2165-145-2-137-b11","doi-asserted-by":"crossref","unstructured":"Casas CG, Catal\u00e0 A, Hern\u00e1ndez GC, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183(1): 71\u2013 77. doi:10.1111\/bjd.19163","DOI":"10.1111\/bjd.19163"},{"key":"2021012621544343600_i1543-2165-145-2-137-b12","doi-asserted-by":"crossref","unstructured":"Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020; 83(1): 280\u2013 285. doi:10.1016\/j.jaad.2020.04.044","DOI":"10.1016\/j.jaad.2020.04.044"},{"key":"2021012621544343600_i1543-2165-145-2-137-b13","doi-asserted-by":"crossref","unstructured":"Verheyden M, Grosber M, Gutermuth J, Velkeniers B. Relapsing symmetric livedo reticularis in a patient with COVID-19 infection [published online June 25, 2020]. J Eur Acad Dermatol Venereol. doi:10.1111\/jdv.16773","DOI":"10.1111\/jdv.16773"},{"key":"2021012621544343600_i1543-2165-145-2-137-b14","doi-asserted-by":"crossref","unstructured":"Sanchez A, Sohier P, Benghanem S, et al. Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection [published online April 30, 2020]. JAMA Dermatol. doi:10.1001\/jamadermatol.2020.1704","DOI":"10.1001\/jamadermatol.2020.1704"},{"key":"2021012621544343600_i1543-2165-145-2-137-b15","unstructured":"Zhang Y, Cao W, Xiao M, et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia [in Chinese]. Zhonghua Xue Ye Xue Za Zhi. 2020; 41(0): E006. doi:10.3760\/cma.j.issn.0253-2727.2020.0006"},{"key":"2021012621544343600_i1543-2165-145-2-137-b16","doi-asserted-by":"crossref","unstructured":"Janah H, Zinebi A, Elbenaye J. Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2. J Eur Acad Dermatol Venereol. 2020; 34(8): e373\u2013 e375. doi:10.1111\/jdv.16623","DOI":"10.1111\/jdv.16623"},{"key":"2021012621544343600_i1543-2165-145-2-137-b17","doi-asserted-by":"crossref","unstructured":"Kolivras A, Dehavay F, Delplace D, et al. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathological findings. JAAD Case Rep. 2020; 6(6): 489\u2013 492. doi:10.1016\/j.jdcr.2020.04.011","DOI":"10.1016\/j.jdcr.2020.04.011"},{"key":"2021012621544343600_i1543-2165-145-2-137-b18","doi-asserted-by":"crossref","unstructured":"Recalcati S, Barbagallo T, Frasin LA, et al. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020; 34(8): e346\u2013 e347. doi:10.1111\/jdv.16533","DOI":"10.1111\/jdv.16533"},{"key":"2021012621544343600_i1543-2165-145-2-137-b19","doi-asserted-by":"crossref","unstructured":"Andina D, Noguera-Morel L, Bascuas-Arribas M, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020; 37(3): 406\u2013 411. doi:10.1111\/pde.14215","DOI":"10.1111\/pde.14215"},{"key":"2021012621544343600_i1543-2165-145-2-137-b20","doi-asserted-by":"crossref","unstructured":"Kanitakis J, Lesort C, Danset M, Jullien D. Chilblain-like acral lesions during the COVID-19 pandemic (\u201cCOVID toes\u201d): histologic, immunofluorescence, and immunohistochemical study of 17 cases. J Am Acad Dermatol. 2020; 83(3): 870\u2013 875. doi:10.1016\/j.jaad.2020.05.145","DOI":"10.1016\/j.jaad.2020.05.145"},{"key":"2021012621544343600_i1543-2165-145-2-137-b21","doi-asserted-by":"crossref","unstructured":"Colmenero I, Santonja C, Alonso-Ria\u00f1o M, et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020; 183(4): 729\u2013 737. doi:10.1111\/bjd.19327","DOI":"10.1111\/bjd.19327"},{"key":"2021012621544343600_i1543-2165-145-2-137-b22","doi-asserted-by":"crossref","unstructured":"Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, et al. Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak [published online April 24, 2020]. J Am Acad Dermatol. doi:10.1016\/j.jaad.2020.04.093","DOI":"10.1016\/j.jaad.2020.04.093"},{"key":"2021012621544343600_i1543-2165-145-2-137-b23","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Robles J, de la Hera I, Pardo J, Mart\u00ednez J, Cutillas-Marco E. Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic [published online May 5, 2020]. Clin Exp Dermatol. doi:10.1111\/ced.14275","DOI":"10.1111\/ced.14275"},{"key":"2021012621544343600_i1543-2165-145-2-137-b24","doi-asserted-by":"crossref","unstructured":"Docampo-Sim\u00f3n A, S\u00e1nchez-Pujol MJ, Juan-Carpena G, et al. Are chilblain-like acral skin lesions really indicative of COVID-19?: a prospective study and literature review [published online June 15, 2020]. J Eur Acad Dermatol Venereol. doi:10.1111\/jdv.16665","DOI":"10.1111\/jdv.16665"},{"key":"2021012621544343600_i1543-2165-145-2-137-b25","doi-asserted-by":"crossref","unstructured":"Black JRM, Bailey C, Przewrocka J, Dijkstra KK, Swanton C. COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet. 2020; 395(10234): 1418\u2013 1420. doi:10.1016\/S0140-6736(20)30917-X","DOI":"10.1016\/S0140-6736(20)30917-X"},{"key":"2021012621544343600_i1543-2165-145-2-137-b26","doi-asserted-by":"crossref","unstructured":"Stubblefield WB, Talbot HK, Feldstein L, et al. Seroprevalence of SARS-CoV-2 among frontline healthcare personnel during the first month of caring for COVID-19 patients\u2014Nashville, Tennessee [published online July 6, 2020]. Clin Infect Dis. doi:10.1093\/cid\/ciaa936","DOI":"10.1093\/cid\/ciaa936"},{"key":"2021012621544343600_i1543-2165-145-2-137-b27","doi-asserted-by":"crossref","unstructured":"Rivett L, Sridhar S, Sparkes D, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife. 2020; 9: e58728. doi:10.7554\/eLife.58728","DOI":"10.7554\/eLife.58728"},{"key":"2021012621544343600_i1543-2165-145-2-137-b28","doi-asserted-by":"crossref","unstructured":"Piccolo V, Neri I, Filippeschi C, et al. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients [published online April 24, 2020]. J Eur Acad Dermatol Venereol. doi:10.1111\/jdv.16526","DOI":"10.1111\/jdv.16526"},{"key":"2021012621544343600_i1543-2165-145-2-137-b29","doi-asserted-by":"crossref","unstructured":"Cribier B, Djeridi N, Peltre B, Grosshans E. A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol. 2001; 45(6): 924\u2013 929. doi:10.1067\/mjd.2001.117861","DOI":"10.1067\/mjd.2001.117861"},{"key":"2021012621544343600_i1543-2165-145-2-137-b30","doi-asserted-by":"crossref","unstructured":"Frieman M, Heise M, Baric R. SARS coronavirus and innate immunity. Virus Res. 2008; 133(1): 101\u2013 112. doi:10.1016\/j.virusres.2007.03.015","DOI":"10.1016\/j.virusres.2007.03.015"},{"key":"2021012621544343600_i1543-2165-145-2-137-b31","doi-asserted-by":"crossref","unstructured":"Kindler E, Thiel V, Weber F. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv Virus Res. 2016; 96: 219\u2013 243. doi:10.1016\/bs.aivir.2016.08.006","DOI":"10.1016\/bs.aivir.2016.08.006"},{"key":"2021012621544343600_i1543-2165-145-2-137-b32","doi-asserted-by":"crossref","unstructured":"Haagmans BL, Kuiken T, Martina BE, et al. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med. 2004; 10(3): 290\u2013 293. doi:10.1038\/nm1001","DOI":"10.1038\/nm1001"},{"key":"2021012621544343600_i1543-2165-145-2-137-b33","doi-asserted-by":"crossref","unstructured":"Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008; 134(4): 587\u2013 598. doi:10.1016\/j.cell.2008.06.032","DOI":"10.1016\/j.cell.2008.06.032"},{"key":"2021012621544343600_i1543-2165-145-2-137-b34","doi-asserted-by":"crossref","unstructured":"Rice GI, Bond J, Asipu A, et al. Mutations involved in Aicardi-Gouti\u00e8res syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet. 2009; 41(7): 829\u2013 832. doi:10.1038\/ng.373","DOI":"10.1038\/ng.373"},{"key":"2021012621544343600_i1543-2165-145-2-137-b35","doi-asserted-by":"crossref","unstructured":"Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009; 461(7265): 788\u2013 792. doi:10.1038\/nature08476","DOI":"10.1038\/nature08476"},{"key":"2021012621544343600_i1543-2165-145-2-137-b36","doi-asserted-by":"crossref","unstructured":"Vermi W, Lonardi S, Morassi M, et al. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus: selective tropism at the site of epithelial apoptotic damage. Immunobiology. 2009; 214(9\u201310): 877\u2013 886. doi:10.1016\/j.imbio.2009.06.013","DOI":"10.1016\/j.imbio.2009.06.013"},{"key":"2021012621544343600_i1543-2165-145-2-137-b37","doi-asserted-by":"crossref","unstructured":"Tomasini D, Mentzel T, Hantschke M, et al. Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner's lymphocytic infiltrate of the skin and cutaneous lupus erythematosus. J Cutan Pathol. 2010; 37(11): 1132\u2013 1139. doi:10.1111\/j.1600-0560.2010.01587.x","DOI":"10.1111\/j.1600-0560.2010.01587.x"},{"key":"2021012621544343600_i1543-2165-145-2-137-b38","doi-asserted-by":"crossref","unstructured":"Colonna M, Trinchieri G, Liu Y-J. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004; 5(12): 1219\u2013 1226. doi:10.1038\/ni1141","DOI":"10.1038\/ni1141"},{"key":"2021012621544343600_i1543-2165-145-2-137-b39","doi-asserted-by":"crossref","unstructured":"Cervantes-Barragan L, Z\u00fcst R, Weber F, et al. Control of coronavirus infection through plasmacytoid dendritic-cell\u2013derived type I interferon. Blood. 2007; 109(3): 1131\u2013 1137. doi:10.1182\/blood-2006-05-023770","DOI":"10.1182\/blood-2006-05-023770"},{"key":"2021012621544343600_i1543-2165-145-2-137-b40","doi-asserted-by":"crossref","unstructured":"Channappanavar R, Fehr AR, Vijay R, et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016; 19(2): 181\u2013 193. doi:10.1016\/j.chom.2016.01.007","DOI":"10.1016\/j.chom.2016.01.007"},{"key":"2021012621544343600_i1543-2165-145-2-137-b41","doi-asserted-by":"crossref","unstructured":"Scheuplein VA, Seifried J, Malczyk AH, et al. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol. 2015; 89(7): 3859\u2013 3869. doi:10.1128\/JVI.03607-14","DOI":"10.1128\/JVI.03607-14"},{"key":"2021012621544343600_i1543-2165-145-2-137-b42","doi-asserted-by":"crossref","unstructured":"Channappanavar R, Fehr AR, Zheng J, et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019; 130: 3625\u2013 3639. doi:10.1172\/JCI126363","DOI":"10.1172\/JCI126363"},{"key":"2021012621544343600_i1543-2165-145-2-137-b43","doi-asserted-by":"crossref","unstructured":"Zangrillo A, Beretta L, Scandroglio AM, et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy [published online April 23, 2020]. Crit Care Resusc. 2020.","DOI":"10.1016\/S1441-2772(23)00387-3"},{"key":"2021012621544343600_i1543-2165-145-2-137-b44","doi-asserted-by":"crossref","unstructured":"Michael Henry B, Vikse J, Benoit S, Favaloro EJ, Lippi G . Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020; 507: 167\u2013 173. doi:10.1016\/j.cca.2020.04.027","DOI":"10.1016\/j.cca.2020.04.027"},{"key":"2021012621544343600_i1543-2165-145-2-137-b45","doi-asserted-by":"crossref","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2): 631\u2013 637. doi:10.1002\/path.1570","DOI":"10.1002\/path.1570"},{"key":"2021012621544343600_i1543-2165-145-2-137-b46","doi-asserted-by":"crossref","unstructured":"Monteil V, Kwon H, Prado P, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020; 81(4): 905\u2013 913.e7. doi:10.1016\/j.cell.2020.04.004","DOI":"10.1016\/j.cell.2020.04.004"},{"key":"2021012621544343600_i1543-2165-145-2-137-b47","doi-asserted-by":"crossref","unstructured":"Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234): 1417\u2013 1418. doi:10.1016\/S0140-6736(20)30937-5","DOI":"10.1016\/S0140-6736(20)30937-5"},{"key":"2021012621544343600_i1543-2165-145-2-137-b48","doi-asserted-by":"crossref","unstructured":"Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020; 142(1): 68\u2013 78. doi:10.1161\/CIRCULATIONAHA.120.047549","DOI":"10.1161\/CIRCULATIONAHA.120.047549"},{"key":"2021012621544343600_i1543-2165-145-2-137-b49","doi-asserted-by":"crossref","unstructured":"Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020; 220: 1\u2013 13. doi:10.1016\/j.trsl.2020.04.007","DOI":"10.1016\/j.trsl.2020.04.007"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/145\/2\/137\/2715919\/i1543-2165-145-2-137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/145\/2\/137\/2715919\/i1543-2165-145-2-137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:09Z","timestamp":1764790869000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/145\/2\/article-p137.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,10,9]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2020-0613-sa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}